Related references
Note: Only part of the references are listed.Assessment of COVID-19 Hospitalizations by Race/Ethnicity in 12 States
Pinar Karaca-Mandic et al.
JAMA INTERNAL MEDICINE (2021)
Determination of SARS-CoV-2 antibodies with assays from Diasorin, Roche and IDvet
Alexander Kruettgen et al.
JOURNAL OF VIROLOGICAL METHODS (2021)
Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020
Kristina L. Bajema et al.
JAMA INTERNAL MEDICINE (2021)
The FDA's Experience with Covid-19 Antibody Tests
Jeffrey Shuren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection
Pyoeng Gyun Choe et al.
EMERGING INFECTIOUS DISEASES (2021)
Racial demographics and COVID-19 confirmed cases and deaths: a correlational analysis of 2886 US counties
Uma Mahajan et al.
JOURNAL OF PUBLIC HEALTH (2020)
Differential occupational risk for COVID-19 and other infection exposure according to race and ethnicity
Devan Hawkins
AMERICAN JOURNAL OF INDUSTRIAL MEDICINE (2020)
Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York
Eli S. Rosenberg et al.
ANNALS OF EPIDEMIOLOGY (2020)
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020
Fiona P. Havers et al.
JAMA INTERNAL MEDICINE (2020)
Estimated Community Seroprevalence of SARS-CoV-2 Antibodies - Two Georgia Counties, April 28-May 3, 2020
Holly M. Biggs et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample - Indiana, April 25-29, 2020
Nir Menachemi et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area
Joseph Moscola et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
A. J. Jaaskelainen et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Ethnic and racial disparities in COVID-19-related deaths: counting the trees, hiding the forest
Sanni Yaya et al.
BMJ GLOBAL HEALTH (2020)
Estimation Without Representation: Early Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Studies and the Path Forward
Bonnie E. Shook-Sa et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani et al.
NATURE (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts
Vivek Naranbhai et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study
Shuchi Anand et al.
LANCET (2020)
Substantial underestimation of SARS-CoV-2 infection in the United States
Sean L. Wu et al.
NATURE COMMUNICATIONS (2020)
Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network-13 Academic Medical Centers, April-June 2020
Wesley H. Self et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays
Anna E. Merrill et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2020)
Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City
Daniel Stadlbauer et al.
NATURE (2020)
Rethinking Response Rates: New Evidence of Little Relationship Between Survey Response Rates and Nonresponse Bias
Richard Hendra et al.
EVALUATION REVIEW (2019)
Validation of self-reported influenza vaccination in the current and prior season
Jennifer P. King et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2018)
Share Paper
